<HashMap><database>biostudies-literature</database><scores/><additional><submitter>Wang B</submitter><funding>NIGMS NIH HHS</funding><pagination>134450</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC9634955</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>433(Pt 1)</volume><pubmed_abstract>Myocardial infarction (MI) is a major cause of disability and mortality worldwide. A cell permeable peptide V1-Cal has shown remarkable therapeutic effects on ML However, using V1-Cal to improve long-term cardiac function after MI is presently limited by its short half-life. Herein, we co-assembled V1-Cal with a well-known hydrogelator Nap-Phe-Phe-Tyr (NapFFY) to obtain a new supramolecular hydrogel V1-Cal/NapFFY. We found that the hydrogel could significantly enhance the therapeutic effects of V1-Cal on ventricular remodeling reduction and cardiac function improvement in a myocardial infarction rat model. &lt;i>In vitro&lt;/i> experiments indicated that co-assembly of V1-Cal with NapFFY significantly increased mechanic strength of the hydrogel, enabling a sustained release of V1-Cal for more th</pubmed_abstract><journal>Chemical engineering journal (Lausanne, Switzerland : 1996)</journal><pubmed_title>V1-Cal hydrogelation enhances its effects on ventricular remodeling reduction and cardiac function improvement post myocardial infarction.</pubmed_title><pmcid>PMC9634955</pmcid><funding_grant_id>R35 GM119522</funding_grant_id><pubmed_authors>Gross ER</pubmed_authors><pubmed_authors>Wang B</pubmed_authors><pubmed_authors>Wang C</pubmed_authors><pubmed_authors>Wang D</pubmed_authors><pubmed_authors>Tao H</pubmed_authors><pubmed_authors>Li F</pubmed_authors><pubmed_authors>Wu C</pubmed_authors><pubmed_authors>Pang X</pubmed_authors><pubmed_authors>He S</pubmed_authors><pubmed_authors>Liang G</pubmed_authors><pubmed_authors>Zhang Y</pubmed_authors><pubmed_authors>Wang Y</pubmed_authors><pubmed_authors>Yuan Y</pubmed_authors></additional><is_claimable>false</is_claimable><name>V1-Cal hydrogelation enhances its effects on ventricular remodeling reduction and cardiac function improvement post myocardial infarction.</name><description>Myocardial infarction (MI) is a major cause of disability and mortality worldwide. A cell permeable peptide V1-Cal has shown remarkable therapeutic effects on ML However, using V1-Cal to improve long-term cardiac function after MI is presently limited by its short half-life. Herein, we co-assembled V1-Cal with a well-known hydrogelator Nap-Phe-Phe-Tyr (NapFFY) to obtain a new supramolecular hydrogel V1-Cal/NapFFY. We found that the hydrogel could significantly enhance the therapeutic effects of V1-Cal on ventricular remodeling reduction and cardiac function improvement in a myocardial infarction rat model. &lt;i>In vitro&lt;/i> experiments indicated that co-assembly of V1-Cal with NapFFY significantly increased mechanic strength of the hydrogel, enabling a sustained release of V1-Cal for more th</description><dates><release>2022-01-01T00:00:00Z</release><publication>2022 Apr</publication><modification>2025-05-31T22:57:25.805Z</modification><creation>2025-05-31T22:57:25.805Z</creation></dates><accession>S-EPMC9634955</accession><cross_references><pubmed>36338580</pubmed><doi>10.1016/j.cej.2021.134450</doi></cross_references></HashMap>